Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by mdjbrownon May 10, 2021 9:26am
148 Views
Post# 33163931

RE:RE:New informative video about Medipharm!

RE:RE:New informative video about Medipharm!Agreed Redwine

The international distribution seeds being sewn now will bear fruit later, and in my opinion those shorting Medipharm when trading at all time lows are taking a big risk.

Akin to buying shares at all time highs which rarely works out.

Tapping the Israel cbd market is huge, when considering all the scientific medical research that comes out of that country.

Time will tell, but a steady increase in revenue will send profits soaring and that will translate into much higher shareprices. 

Lets see what tune Q1 financials belt out, but my guess is increased quarter over quarter revenue, which is exactly what we as shareholders want to hear with each passing quarter.



Play us a song, Mr. Piano Man!


<< Previous
Bullboard Posts
Next >>